Avidity NanoMedicines Receives $6,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc3d8211-9c9b-4902-9f50-eb3c0f5d4d5d - Date
10/8/2014 - Company Name
Avidity NanoMedicines - Mailing Address
11119 North Torrey Pines Road La Jolla, CA 92037 USA - Company Description
Avidity NanoMedicines is advancing a new class of drug candidates, antibody-siRNA complexes (ARCs™), which draw on the best features of both antibody-drug conjugates and nucleic acid-based medicines and which utilize nano-scale self-assembly to create a transformative approach to the treatment of cancer and other serious diseases. - Website
http://www.aviditynano.com - Transaction Type
Venture Equity - Transaction Amount
$6,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds from the financing will be used to advance new cancer therapies that utilize the company’s proprietary antibody-siRNA complex (ARC™) platform. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
